[1] 崔琦,杨春杰,曹贵文,等.血清C肽与2型糖尿病下肢动脉硬化的关[J].实用医学杂志,2015,31(23):3869-3872. [2] 刘霞,邱杰,斯琴.2型糖尿病患者住院医疗费用的通径分析[J].中国卫生统计,2015,32(2):366-368. [3] YANGR, ZANG WJ, LI TW, et al. Early detection of lesions of dorsal artery of foot in patients with type 2 diabetes mellitus by high-frequency ultrasonography[J]. Journal of Huazhong University of Science and Technology,2013,57(3):297-305. [4] MA RC, LEE HM, LAM VK, et al. Familial young-onset diabetes, pre-diabetes and cardiovasular disease are associated with genetic variants of DACHI in Chinese[J]. PloS One,2014,9(1):84770. [5] 单洁,田霖林,马琳,等.2型糖尿病下肢动脉硬化闭塞相关因素分析[J].中外医疗,2015,38(11):16-18. [6] 李艳宁,李芬,李智贤,等.2型糖尿病下肢动脉病变程度与其危险因素的相关性研究[J].广西医学,2013,35(4):385-388. [7] WANG LS, LIN P, MA AX, et al. C-Peptide is independently associated with an increased risk of coronary artery disease in T2DM subjects: A cross-sectional study[J]. PloS One,2015,10(6):1-11. [8] 刘瑜,宋康兴.介入溶栓结合血管成形术治疗老年下肢动脉闭塞1例分析[J].中华老年多器官疾病杂志,2013,12(4):316-317. [9] 单洁.2型糖尿病患者下肢动脉硬化与血压、血脂及内皮功能等因素的相关性[J].中国老年学杂志,2014,34(20):3653-3654. [10]KLUZ J,MALECKI R,ADAMIEC R et al. Practical importance and modern methods of the evaluation of skin microcirculation during chronic lower limb ischemia in patients with peripheral arterial occlusive disease and/ or diabetes[J]. Int Angiol,2013,32(1):42-51. [11]RABCZYNSKI M, FIODORENKO-DUMAS I, ADAMIEC R, et al. Role of anti-HSP 60/65 antibodies in atherogenesis in patients with type 2 diabetes and lower limb ischemia[J]. J Physiol Pharmacol,2012,63(6):691-696. [12]席殿梅,路伟,卫茂华,等.2型糖尿病患者下肢动脉硬化与血压、血脂及其内皮功能的相关性[J].西部医学,2016,28(2):225-227. |